semaglutide and percocet Novo Nordisk Files Patent Lawsuit Against Hims & Hers Over Compounded Products GLP-1 Agent May Hold Opioid

(35) Conclusion GLP-1 receptor agonists are becoming integral to obesity and diabetes management, with significant implications for orthopedic surgery

The mean BMI of the study participants was 36.3 kg/m 2 , whereas the mean UACR was 251 mg/g

There has been a broad perception that these medications do more harm than good that at a time when many people struggle to manage their diabetes, why overload them with more than they can handle

In September 2025, the Food and Drug Administration issued over 50 Warning Letters to companies for marketing compounded GLPs as generic versions or that make comparative claims to FDA-approved versions

Target 1.2 to 1.6 grams of protein per kilogram of body weight per day during weight loss